Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Goodwill (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Goodwill for 16 consecutive years, with $9.6 million as the latest value for Q4 2025.

  • Quarterly Goodwill fell 83.03% to $9.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.6 million through Dec 2025, down 83.03% year-over-year, with the annual reading at $9.6 million for FY2025, 83.03% down from the prior year.
  • Goodwill for Q4 2025 was $9.6 million at Harvard Bioscience, roughly flat from $9.5 million in the prior quarter.
  • The five-year high for Goodwill was $58.4 million in Q2 2021, with the low at $9.0 million in Q1 2025.
  • Average Goodwill over 5 years is $47.4 million, with a median of $56.6 million recorded in 2023.
  • The sharpest move saw Goodwill increased 2.57% in 2021, then crashed 84.2% in 2025.
  • Over 5 years, Goodwill stood at $57.7 million in 2021, then dropped by 2.48% to $56.3 million in 2022, then rose by 1.43% to $57.1 million in 2023, then dropped by 1.3% to $56.3 million in 2024, then tumbled by 83.03% to $9.6 million in 2025.
  • According to Business Quant data, Goodwill over the past three periods came in at $9.6 million, $9.5 million, and $10.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.